Over-expression of HMGA1 (High-Mobility Group A1) promotes anoikis resistance in pancreatic adenocarcinoma cells through a PI3-K/Akt-dependent mechanism, leading to increased Akt phosphorylation and kinase activity and reduced caspase 3 activation [250]. Here, AKT1 is linked to pancreatic adenocarcinoma.